BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12610352)

  • 21. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.
    Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M
    Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
    Lee J; Hasteh F
    Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid cell nests in Hashimoto's thyroiditis sharing features with papillary thyroid microcarcinoma.
    Asioli S; Erickson LA; Lloyd RV
    Endocr Pathol; 2009; 20(4):197-203. PubMed ID: 19809803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DISTRIBUTION OF SEX HORMONES AND LYMPHOCYTES IN REPRODUCTIVE WOMAN WITH THYROID PAPILLARY CARCINOMA AND HASHIMOTO'S THYROIDITIS.
    Muzashvili T; Kepuladze S; Gachechiladze M; Burkadze G
    Georgian Med News; 2020 Oct; (307):193-200. PubMed ID: 33270603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoblastoma-repression of E2F-dependent transcription depends on the ability of the retinoblastoma protein to interact with E2F and is abrogated by the adenovirus E1A oncoprotein.
    Arroyo M; Raychaudhuri P
    Nucleic Acids Res; 1992 Nov; 20(22):5947-54. PubMed ID: 1461728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases.
    Berho M; Suster S
    Hum Pathol; 1997 Jan; 28(1):47-53. PubMed ID: 9013831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinico-pathological features of papillary thyroid cancer coexistent with Hashimoto's thyroiditis].
    Molnár S; Győry F; Nagy E; Méhes G; Molnár C
    Orv Hetil; 2017 Feb; 158(5):178-182. PubMed ID: 28132543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription factor-mediated proliferation and apoptosis in benign and malignant thyroid lesions.
    Letsas KP; Frangou-Lazaridis M; Skyrlas A; Tsatsoulis A; Malamou-Mitsi V
    Pathol Int; 2005 Nov; 55(11):694-702. PubMed ID: 16271081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rb and E2F-1 regulate telomerase activity in human cancer cells.
    Crowe DL; Nguyen DC
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
    Flemington EK; Speck SH; Kaelin WG
    Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis.
    Ruco LP; Stoppacciaro A; Ballarini F; Prat M; Scarpino S
    J Pathol; 2001 May; 194(1):4-8. PubMed ID: 11329134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Warthin-like papillary carcinoma of the thyroid.
    Baloch ZW; LiVolsi VA
    Arch Pathol Lab Med; 2000 Aug; 124(8):1192-5. PubMed ID: 10923082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis.
    Shan B; Durfee T; Lee WH
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):679-84. PubMed ID: 8570615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G
    Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
    Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Weintraub SJ; Chow KN; Luo RX; Zhang SH; He S; Dean DC
    Nature; 1995 Jun; 375(6534):812-5. PubMed ID: 7596417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
    Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.